Evaluation of Satisfaction Regarding Patient's Management of Ocular Surface Diseases
NCT ID: NCT01091311
Last Updated: 2011-06-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
30 participants
INTERVENTIONAL
2010-05-31
2010-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Its objective is to Collect information from patients and ophthalmologists specialized in ocular surface and eyelids to anticipate how Blephasteam ® can be optimized.
This study involves 2 visits, visit of Inclusion, J0, then end of study visit, D21.
Between the two visits patients will be treated with Blephasteam ® for 21 days (up to two uses per day) and complete a questionnaire every two days during the first week and then once a week the next two weeks.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Satisfaction Regarding Patient's Management of Ocular Surface Diseases
NCT01189474
Warming Efficiency of Warm Compresses Versus BLEPHASTEAM® in Eyelid Therapy
NCT01190397
Clinical Safety Study on an Eyelid Warming Device to Evaluate the Eyelid and Cornea Temperature in Healthy Volunteers
NCT01086943
Meibomian Gland Dysfunction Management
NCT03652337
Management of Eyelid Disorders by Ophthalmologists in Usual Medical Practice
NCT01552174
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Blephasteam
Eye lid warming goggles
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
4 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Laboratoires Thea
INDUSTRY
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Christophe Baudouin, Professor
Role: PRINCIPAL_INVESTIGATOR
Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts
Frédéric Chiambaretta, Professor
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Clermont-Ferrand
Serge Doan, Doctor
Role: PRINCIPAL_INVESTIGATOR
Hopital Bichat
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hôpital Gabriel Montpied
Clermont-Ferrand, , France
C.H.N.O des XV-XX
Paris, , France
Hôpital Bichat - Claude Bernard
Paris, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
N° RCB 2010-A00017-32
Identifier Type: OTHER
Identifier Source: secondary_id
LT2420-PIV-CE-01/10
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.